Skip to main content
. 2005 Apr;11(4):546–553. doi: 10.3201/eid1104.040699

Figure 2.

Figure 2

Evolution of community quinolone consumption and prevalence of resistance to ciprofloxacin in invasive community-acquired Escherichia coli infections (European Antimicrobial Resistance Surveillance System–Spain 2001–2003). DDD, defined daily doses. 1, January–June; 2, July–December.